Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Status
- RECRUITING
- Phase
- PHASE2
A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah
- Status
- WITHDRAWN
- Phase
- PHASE1
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE1
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
- Status
- RECRUITING
- Phase
- N/A
Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
- Status
- RECRUITING
- Phase
- PHASE1
FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
- Status
- COMPLETED
- Phase
- PHASE1
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
- Status
- TERMINATED
- Phase
- PHASE1